Since the granting of a CE Mark for VitroGro was considered to...

Since the granting of a CE Mark for VitroGro was considered to be imminent just over 2 years ago, and the extraordinary number of regulatory obstacles that have subsequently unfolded, I keep asking myself the following questions:
* If the product in question belonged to one of the major pharmaceutical companies, would it have received such intense scrutiny?
* Who stands to benefit from the delay?
* Is the system open to corruption? Surely not ;)

Perhaps I just have a suspicious mind, but it would be interesting to know if anyone else has had the same thoughts.